Eli Casdin - Net Worth and Insider Trading

Eli Casdin Net Worth

The estimated net worth of Eli Casdin is at least $239 Million dollars as of 2024-04-29. Eli Casdin is the Director of IPSCO Tubulars Inc and owns about 5,662,760 shares of IPSCO Tubulars Inc (IPSC) stock worth over $175 Million. Eli Casdin is the Director of Absci Corp and owns about 7,718,593 shares of Absci Corp (ABSI) stock worth over $35 Million. Eli Casdin is also the Director of Tenaya Therapeutics Inc and owns about 6,078,860 shares of Tenaya Therapeutics Inc (TNYA) stock worth over $26 Million. Besides these, Eli Casdin also holds Standard BioTools Inc (LAB) . Details can be seen in Eli Casdin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Eli Casdin has not made any transactions after 2023-05-19 and currently still holds the listed stock(s).

Transaction Summary of Eli Casdin

To

Eli Casdin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eli Casdin owns 14 companies in total, including CM Life Sciences Inc (CMLFU) , Exact Sciences Corp (EXAS) , and BioLife Solutions Inc (BLFS) among others .

Click here to see the complete history of Eli Casdin’s form 4 insider trades.

Insider Ownership Summary of Eli Casdin

Ticker Comapny Transaction Date Type of Owner
CMLFU CM Life Sciences Inc 2020-09-01 director & 10 percent owner & Chief Executive Officer
EXAS Exact Sciences Corp 2017-10-26 director
BLFS BioLife Solutions Inc 2018-08-10 10 percent owner
GBIO Generation Bio Co 2020-06-11 10 percent owner
FULC Fulcrum Therapeutics Inc 2019-07-17 10 percent owner
CNST Constellation Pharmaceuticals Inc 2018-07-23 10 percent owner
LAB Standard BioTools Inc 2023-05-19 director & 10 percent owner
MXCT MaxCyte Inc 2021-07-29 10 percent owner
ABSI Absci Corp 2021-07-26 director & 10 percent owner
WGS GeneDx Holdings Corp 2023-01-31 director & 10 percent owner
SLGC SomaLogic Inc 2022-09-29 director
EQRX EQRx Inc 2021-12-17 director & 10 percent owner
IPSC Century Therapeutics Inc 2022-06-09 director
TNYA Tenaya Therapeutics Inc 2022-11-17 director

Eli Casdin Latest Holdings Summary

Eli Casdin currently owns a total of 4 stocks. Among these stocks, Eli Casdin owns 5,662,760 shares of IPSCO Tubulars Inc (IPSC) as of June 22, 2021, with a value of $175 Million and a weighting of 73.03%. Eli Casdin owns 7,718,593 shares of Absci Corp (ABSI) as of July 26, 2021, with a value of $35 Million and a weighting of 14.76%. Eli Casdin also owns 6,078,860 shares of Tenaya Therapeutics Inc (TNYA) as of November 17, 2022, with a value of $26 Million and a weighting of 10.94%. The other 1 stocks Standard BioTools Inc (LAB) have a combined weighting of 1.27% among all his current holdings.

Latest Holdings of Eli Casdin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IPSC IPSCO Tubulars Inc 2021-06-22 5,662,760 30.88 174,866,029
ABSI Absci Corp 2021-07-26 7,718,593 4.58 35,351,156
TNYA Tenaya Therapeutics Inc 2022-11-17 6,078,860 4.31 26,199,887
LAB Standard BioTools Inc 2023-05-19 1,246,766 2.44 3,042,109

Holding Weightings of Eli Casdin


Eli Casdin Form 4 Trading Tracker

According to the SEC Form 4 filings, Eli Casdin has made a total of 1 transactions in IPSCO Tubulars Inc (IPSC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in IPSCO Tubulars Inc is the acquisition of 750,000 shares on June 22, 2021, which cost Eli Casdin around $15 Million.

According to the SEC Form 4 filings, Eli Casdin has made a total of 1 transactions in Absci Corp (ABSI) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Absci Corp is the acquisition of 1,562,500 shares on July 26, 2021, which cost Eli Casdin around $25 Million.

According to the SEC Form 4 filings, Eli Casdin has made a total of 2 transactions in Tenaya Therapeutics Inc (TNYA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Tenaya Therapeutics Inc is the acquisition of 2,492,042 shares on November 17, 2022, which cost Eli Casdin around $6 Million.

More details on Eli Casdin's insider transactions can be found in the Insider Trading History of Eli Casdin table.

Insider Trading History of Eli Casdin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Eli Casdin Trading Performance

GuruFocus tracks the stock performance after each of Eli Casdin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eli Casdin is 9.65%. GuruFocus also compares Eli Casdin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eli Casdin within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Eli Casdin's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Eli Casdin

Average Return

-61.15%

Average return per transaction

Outperforming Transactions

0%

0 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 3.15 9.65 19.21 -61.15 -60.04
Relative Return to S&P 500(%) 1.54 5.55 16.05 -60.15 -61.3

Eli Casdin Ownership Network

Ownership Network List of Eli Casdin

No Data

Ownership Network Relation of Eli Casdin


Eli Casdin Owned Company Details

What does CM Life Sciences Inc do?

Who are the key executives at CM Life Sciences Inc?

Eli Casdin is the director & 10 percent owner & Chief Executive Officer of CM Life Sciences Inc. Other key executives at CM Life Sciences Inc include and director & 10 percent owner Keith A. Meister .

CM Life Sciences Inc (CMLFU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CM Life Sciences Inc (CMLFU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CM Life Sciences Inc (CMLFU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CM Life Sciences Inc (CMLFU)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CM Life Sciences Inc Insider Transactions

No Available Data

Eli Casdin Mailing Address

Above is the net worth, insider trading, and ownership report for Eli Casdin. You might contact Eli Casdin via mailing address: 1350 Avenue Of The Americas, Suite 1140, New York Ny 10019.

Discussions on Eli Casdin

No discussions yet.